HIV-1 Cell–Cell Contact Drives Nuclear Pore Remodelling to Overcome T Cell Infection Barriers

Study Background and Research Question

Human immunodeficiency virus type 1 (HIV-1) infection of resting CD4+ T cells is a central event in HIV pathogenesis, but longstanding in vitro observations have shown that these cells are highly refractory to cell-free HIV-1 infection. This has led to the widespread use of mitogenic activation protocols in research, introducing confounding alterations to T cell biology and masking the true infection dynamics in vivo. The central question addressed by the reference study is: What mechanistic features enable HIV-1 to infect resting T cells within the complex tissue environment, and how does the mode of viral spread influence the molecular hurdles to infection?

Key Innovation from the Reference Study

The study by Mesner et al. introduces a paradigm shift by demonstrating that HIV-1 can overcome the nuclear import barrier in resting T cells not via mass viral exposure, but through direct cell–cell contact. Specifically, the authors reveal that HIV-1 exploits CD4–LCK–CDK1 signalling during virological synapse (VS) formation to remodel the nuclear pore complex (NPC), thereby licensing nuclear import of the viral capsid and enabling productive infection. This mechanistic insight distinguishes the requirements for nuclear import during cell-free versus cell–cell spread, with direct implications for the understanding of HIV-1 dissemination in lymphoid tissues.

Methods and Experimental Design Insights

To dissect the specific effects of cell–cell contact apart from viral load, the authors engineered an Env-F522Y mutant of HIV-1 NL4.3, allowing them to separate the roles of Env-dependent VS formation from bulk virus transfer. Using advanced super-resolution imaging and a combination of viral and cellular assays, they monitored capsid trafficking, NPC status, and T cell signalling responses. The experimental approach included:

• Establishing co-culture systems of infected donor and uninfected target T cells to model CCS (cell–cell spread).
• Tracking nuclear import of HIV-1 capsid using super-resolution microscopy.
• Employing mutational analysis and pharmacological inhibition to dissect CD4–LCK–CDK1 signalling pathways.
• Quantifying nuclear import efficiency and proviral integration in both resting and activated T cells under various conditions.

This multi-pronged design allowed the team to attribute nuclear import licensing directly to contact-induced signalling rather than increased multiplicity of infection.

Core Findings and Why They Matter

The core findings of the reference article are as follows:

• Resting T cells present a nuclear import bottleneck for HIV-1 infection. Despite the presence of integrated provirus in resting CD4+ T cells in vivo, these cells remain resistant to cell-free viral infection due to an inefficient nuclear import step at the NPC.
• HIV-1 overcomes this barrier by triggering CD4–LCK–CDK1 signalling during cell–cell spread. When an infected T cell contacts an uninfected target, Env engagement with CD4 initiates a signalling cascade involving LCK and CDK1, leading to phosphorylation of nucleoporins and NPC remodelling. This process is independent of cell cycle entry, distinguishing it from mitogenic activation.
• Cell–cell contact accelerates nuclear import in both resting and activated T cells. The licensing effect of contact-induced signalling explains why cell–cell spread (CCS) is the dominant mode of infection in tissue, as it provides both spatial proximity and a unique signalling environment not recapitulated by cell-free virus exposure.
• High-dose cell-free virus exposure does not replicate the effect of CCS. The study confirms that even saturating levels of cell-free HIV-1 cannot efficiently infect resting T cells, emphasizing the functional significance of NPC remodelling during CCS.

This work clarifies a central paradox in HIV biology and highlights the critical role of the nuclear pore as a regulated gate for viral infection, with potential implications for targeting host–virus interactions therapeutically.

Comparison with Existing Internal Articles

While the reference study focuses on the interface of viral signalling and nuclear import in human T cells, related internal research has dissected cell entry mechanisms in other viral systems. For instance, Wang et al. (2018) and follow-up articles demonstrated the specificity of clathrin-mediated endocytosis in grass carp reovirus (GCRV104) entry, using pharmacological inhibitors to define pathway dependence. These studies, while conducted in fish cell models, underscore that viral entry and intracellular trafficking are highly pathway-specific and that experimental dissection via selective inhibitors (e.g., for endocytosis or kinase activity) can clarify viral–host interactions. Similarly, guides such as "IPA-3: Precision Pak1 Inhibition for Kinase and Neurobiology Research" discuss the value of selective kinase inhibitors for mechanistic studies, paralleling the reference study’s use of pathway-specific perturbations to uncover host regulation of infection steps.

Limitations and Transferability

Despite its rigorous design, the reference study’s conclusions are most directly applicable to T cell infection in the context of HIV-1 and may not generalize to other viruses or cell types with different NPC regulation or signalling networks. The reliance on in vitro co-culture systems, while carefully constructed, cannot fully recapitulate the microanatomy and signalling complexity of lymphoid tissue in vivo. Additionally, while the CD4–LCK–CDK1 axis was shown to be necessary for NPC remodelling and infection licensing, the broader range of host factors potentially influencing NPC function in diverse cellular contexts remains to be mapped. Finally, the study’s focus on primary human T cells and relevant HIV-1 strains strengthens relevance but also highlights the technical challenge of translating these findings into therapeutic strategies targeting NPC remodelling or contact-induced signalling without off-target effects.

Protocol Parameters

• Cell–cell spread modeling: Use primary human CD4+ T cells in direct co-culture with infected donor cells to recapitulate virological synapse formation.
• Fusion peptide mutant (Env-F522Y): Employ to separate VS formation from viral transfer for mechanistic studies of contact signalling versus infection multiplicity.
• Kinase activity assays: Apply pathway-specific inhibitors or genetic knockdown to dissect roles of LCK, CDK1, or related kinases during NPC remodelling and infection licensing.
• Super-resolution imaging: Use to quantify nuclear import of HIV-1 capsid and detect NPC phosphorylation status.

Why this cross-domain matters, maturity, and limitations

The cross-talk between viral infection mechanisms, host cell signalling, and nuclear trafficking is a recurring theme in virology and cell biology. The reference study illustrates how viral exploitation of signalling pathways can repurpose cellular machinery—here, the NPC—to overcome infection barriers. While similar approaches using pharmacological inhibitors have proven effective in dissecting viral entry pathways in non-human models (as in grass carp reovirus studies), direct translation to human T cell infection contexts requires careful validation due to the complexity and redundancy of human immune signalling networks. The maturity of this research lies in its ability to integrate advanced imaging, genetic, and pharmacological tools to dissect infection steps with high specificity, but its limitations are inherent in the challenge of targeting such pathways therapeutically without disrupting essential cell functions.

Research Support Resources

To facilitate mechanistic studies of kinase signalling in viral infection or related pathways, researchers may consider using IPA-3 (1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol, SKU B2169), a selective, non-ATP-competitive Pak1 autophosphorylation inhibitor. According to the product information, IPA-3 enables precise modulation of group I PAK kinases in cell-based or kinase activity assays. While the exact pathways targeted in the HIV-1 study differ, the principle of using highly selective kinase inhibitors to dissect infection-relevant signalling can be extended to analogous models in cancer biology research, neuroinflammation, or studies of host–virus interactions. For best results, IPA-3 should be handled according to the recommended solubility and storage guidelines and integrated into established signalling workflows.